0001209191-21-051297.txt : 20210812
0001209191-21-051297.hdr.sgml : 20210812
20210812212456
ACCESSION NUMBER: 0001209191-21-051297
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210810
FILED AS OF DATE: 20210812
DATE AS OF CHANGE: 20210812
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MCGUIRE TERRANCE
CENTRAL INDEX KEY: 0001117003
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40703
FILM NUMBER: 211169442
MAIL ADDRESS:
STREET 1: C/O POLARIS VENTURE PARTNERS LP
STREET 2: 1000 WINTER STREET, SUITE 3350
CITY: WALTHAM
STATE: MA
ZIP: 02154
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Adagio Therapeutics, Inc.
CENTRAL INDEX KEY: 0001832038
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 851403134
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 303 WYMAN STREET
STREET 2: SUITE 300
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: (781) 530-3600
MAIL ADDRESS:
STREET 1: 303 WYMAN STREET
STREET 2: SUITE 300
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-08-10
0
0001832038
Adagio Therapeutics, Inc.
ADGI
0001117003
MCGUIRE TERRANCE
C/O ADAGIO THERAPEUTICS, INC.
303 WYMAN STREET, SUITE 300
WALTHAM
MA
02451
1
0
0
0
Common Stock
2021-08-10
4
C
0
2852425
A
2852425
I
See Footnote
Common Stock
2021-08-10
4
P
0
267769
17.00
A
3120194
I
See Footnote
Common Stock
2021-08-10
4
C
0
55595
A
55595
I
See Footnote
Common Stock
2021-08-10
4
P
0
5219
17.00
A
60814
I
See Footnote
Common Stock
2021-08-10
4
C
0
19540
A
19540
I
See Footnote
Common Stock
2021-08-10
4
P
0
1834
17.00
A
21374
I
See Footnote
Common Stock
2021-08-10
4
C
0
28520
A
28520
I
See Footnote
Common Stock
2021-08-10
4
P
0
2678
17.00
A
31198
I
See Footnote
Common Stock
2021-08-10
4
C
0
4755460
A
4755460
I
See Footnote
Common Stock
2021-08-10
4
P
0
45000
17.00
A
4800460
I
See Footnote
Common Stock
2021-08-10
4
C
0
320160
A
320160
I
See Footnote
Common Stock
2021-08-10
4
P
0
177500
17.00
A
497660
I
See Footnote
Series A Preferred Stock
2021-08-10
4
C
0
361850
0.00
D
Common Stock
1809250
0
I
See Footnote
Series A Preferred Stock
2021-08-10
4
C
0
7052
0.00
D
Common Stock
35260
0
I
See Footnote
Series A Preferred Stock
2021-08-10
4
C
0
2479
0.00
D
Common Stock
12395
0
I
See Footnote
Series A Preferred Stock
2021-08-10
4
C
0
3619
0.00
D
Common Stock
18095
0
I
See Footnote
Series A Preferred Stock
2021-08-10
4
C
0
875000
0.00
D
Common Stock
4375000
0
I
See Footnote
Series B Preferred Stock
2021-08-10
4
C
0
85061
0.00
D
Common Stock
425305
0
I
See Footnote
Series B Preferred Stock
2021-08-10
4
C
0
1658
0.00
D
Common Stock
8290
0
I
See Footnote
Series B Preferred Stock
2021-08-10
4
C
0
583
0.00
D
Common Stock
2915
0
I
See Footnote
Series B Preferred Stock
2021-08-10
4
C
0
850
0.00
D
Common Stock
4250
0
I
See Footnote
Series B Preferred Stock
2021-08-10
4
C
0
44076
0.00
D
Common Stock
220380
0
I
See Footnote
Series C Preferred Stock
2021-08-10
4
C
0
123574
0.00
D
Common Stock
617870
0
I
See Footnote
Series C Preferred Stock
2021-08-10
4
C
0
2409
0.00
D
Common Stock
12045
0
I
See Footnote
Series C Preferred Stock
2021-08-10
4
C
0
846
0.00
D
Common Stock
4230
0
I
See Footnote
Series C Preferred Stock
2021-08-10
4
C
0
1235
0.00
D
Common Stock
6175
0
I
See Footnote
Series C Preferred Stock
2021-08-10
4
C
0
32016
0.00
D
Common Stock
160080
0
I
See Footnote
Series C Preferred
2021-08-10
4
C
0
64032
0.00
D
Common Stock
320160
0
I
See Footnote
Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock automatically converted, without payment of additional consideration, into Common Stock on a 5:1 basis immediately prior to the closing of the Issuer's initial public offering of its Common Stock and had no expiration date.
These shares are held of record by Polaris Venture Partners V, L.P. ("PVP V"). The general partner of PVP V is Polaris Venture Management Co. V, L.L.C. ("PVM V") and may be deemed to have shared voting and investment power with respect to the shares held by PVP V. The Reporting Person is a Managing Member of PVM V and may be deemed to have shared voting and dispositive power over the shares held by PVP V. The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of the Reporting Person's pecuniary interest therein. The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the Reporting Person is the beneficial owner of any securities reported herein.
These shares are held of record by Polaris Venture Partners Entrepreneurs' Fund V, L.P. ("PVPEF V"). The general partner of PVPEF V is PVM V and may be deemed to have shared voting and investment power with respect to the shares held by PVPEF V. The Reporting Person is a Managing Member of PVM V and may be deemed to have shared voting and dispositive power over the shares held by PVPEF V. The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of the Reporting Person's pecuniary interest therein. The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the Reporting Person is the beneficial owner of any securities reported herein.
These shares are held of record by Polaris Venture Partners Founders' Fund V, L.P. ("PVPFF V"). The general partner of PVPFF V is PVM V and may be deemed to have shared voting and investment power with respect to the shares held by PVPFF V. The Reporting Person is a Managing Member of PVM V and may be deemed to have shared voting and dispositive power over the shares held by PVPFF V. The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of the Reporting Person's pecuniary interest therein. The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the Reporting Person is the beneficial owner of any securities reported herein.
These shares are held of record by Polaris Venture Partners Special Founders' Fund V, L.P. ("PVPSFF V"). The general partner of PVPSFF V is PVM V and may be deemed to have shared voting and investment power with respect to the shares held by PVPSFF V. The Reporting Person is a Managing Member of PVM V and may be deemed to have shared voting and dispositive power over the shares held by PVPSFF V. The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of the Reporting Person's pecuniary interest therein. The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the Reporting Person is the beneficial owner of any securities reported herein.
These shares are held of record by Polaris Partners IX, L.P. ("PP IX"). The general partner of PP IX is Polaris Partners GP IX, L.L.C. ("PP GP IX") and may be deemed to have shared voting and investment power with respect to the shares held by PP IX. The Reporting Person holds an interest in PP GP IX and may be deemed to have shared voting and investment power with respect to the shares held by PP IX. The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of the Reporting Person's pecuniary interest therein. The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the Reporting Person is the beneficial owner of any securities reported herein.
These shares are held of record by Polaris Healthcare Technology Opportunities Fund, L.P. ("PHCT"). The general partner of PHCT is Polaris Healthcare Technology Opportunities Fund GP, L.L.C. ("PHCT GP") and may be deemed to have shared voting and investment power with respect to the shares held by PHCT. The Reporting Person holds an interest in PHCT GP and may be deemed to have shared voting and investment power with respect to the shares held by PHCT. The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of the Reporting Person's pecuniary interest therein. The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the Reporting Person is the beneficial owner of any securities reported herein.
/s/ Dorothy Vinsky, Attorney-in-Fact
2021-08-12